Trial Profile
Molecular and Cellular Mechanism in the course of Immunotherapy with a Phleum Pratense Oral Lyophilisate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Grass pollen hypersensitivity
- Focus Biomarker; Pharmacodynamics
- Sponsors ALK-Abello
- 19 Aug 2020 Results published in the Allergy
- 05 Aug 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.